drugset

drugset / Trial / NCT07720115

Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer

NCT07720115 ↗

Phase 2 Withdrawn M.D. Anderson Cancer Center

NaSingle-groupOpen-labelTreatment

Summary

To learn if the experimental drug S-531011 plus RadScopalTM radiation therapy can help to control previously treated metastatic colorectal cancer.

Timeline

Start: 2026-08-12
Primary completion: 2026-09-04
Completion: 2026-09-04

Outcome

Outcome not reported

Stopped: “0 participants”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	S-531011	Unknown	—	Intravenous

Indications